These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30615933)

  • 21. Activity-Dependent Dysfunction in Visual and Olfactory Sensory Systems in Mouse Models of Down Syndrome.
    William CM; Saqran L; Stern MA; Chiang CL; Herrick SP; Rangwala A; Albers MW; Frosch MP; Hyman BT
    J Neurosci; 2017 Oct; 37(41):9880-9888. PubMed ID: 28899917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Drp1-mediated mitochondrial fission improves mitochondrial dynamics and bioenergetics stimulating neurogenesis in hippocampal progenitor cells from a Down syndrome mouse model.
    Valenti D; Rossi L; Marzulli D; Bellomo F; De Rasmo D; Signorile A; Vacca RA
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3117-3127. PubMed ID: 28939434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.
    Barone E; Arena A; Head E; Butterfield DA; Perluigi M
    Free Radic Biol Med; 2018 Jan; 114():84-93. PubMed ID: 28705658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics: the neglected key to minimize learning and memory deficits in Down syndrome.
    Dekker AD; De Deyn PP; Rots MG
    Neurosci Biobehav Rev; 2014 Sep; 45():72-84. PubMed ID: 24858130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rule-based category learning in Down syndrome.
    Phillips BA; Conners FA; Merrill E; Klinger MR
    Am J Intellect Dev Disabil; 2014 May; 119(3):220-34. PubMed ID: 24871791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards the understanding of Down syndrome using mouse models.
    Yamakawa K
    Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic mechanisms involved in the phenotype of Down syndrome.
    Patterson D
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.
    Parrini M; Ghezzi D; Deidda G; Medrihan L; Castroflorio E; Alberti M; Baldelli P; Cancedda L; Contestabile A
    Sci Rep; 2017 Dec; 7(1):16825. PubMed ID: 29203796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model.
    Valenti D; de Bari L; de Rasmo D; Signorile A; Henrion-Caude A; Contestabile A; Vacca RA
    Biochim Biophys Acta; 2016 Jun; 1862(6):1093-104. PubMed ID: 26964795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
    Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
    Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.
    Rachidi M; Lopes C
    Am J Intellect Dev Disabil; 2010 Mar; 115(2):83-112. PubMed ID: 20441388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma metabolome and cognitive skills in Down syndrome.
    Antonaros F; Ghini V; Pulina F; Ramacieri G; Cicchini E; Mannini E; Martelli A; Feliciello A; Lanfranchi S; Onnivello S; Vianello R; Locatelli C; Cocchi G; Pelleri MC; Vitale L; Strippoli P; Luchinat C; Turano P; Piovesan A; Caracausi M
    Sci Rep; 2020 Jun; 10(1):10491. PubMed ID: 32591596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome.
    Salehi A; Faizi M; Colas D; Valletta J; Laguna J; Takimoto-Kimura R; Kleschevnikov A; Wagner SL; Aisen P; Shamloo M; Mobley WC
    Sci Transl Med; 2009 Nov; 1(7):7ra17. PubMed ID: 20368182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Perspectives for the Rescue of Cognitive Disability in Down Syndrome.
    Bartesaghi R; Haydar TF; Delabar JM; Dierssen M; Martínez-Cué C; Bianchi DW
    J Neurosci; 2015 Oct; 35(41):13843-52. PubMed ID: 26468184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for improving brain function in individuals with Down syndrome.
    Costa AC; Scott-McKean JJ
    CNS Drugs; 2013 Sep; 27(9):679-702. PubMed ID: 23821040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome.
    Corrales A; Vidal R; García S; Vidal V; Martínez P; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
    J Pineal Res; 2014 Jan; 56(1):51-61. PubMed ID: 24147912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors.
    Heller HC; Salehi A; Chuluun B; Das D; Lin B; Moghadam S; Garner CC; Colas D
    Neurobiol Learn Mem; 2014 Dec; 116():162-71. PubMed ID: 25463650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive abilities in individuals with Down syndrome-a narrative review.
    Jafri SK; Harman KE
    Turk J Pediatr; 2020; 62(6):897-905. PubMed ID: 33372428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.
    Goodliffe JW; Olmos-Serrano JL; Aziz NM; Pennings JL; Guedj F; Bianchi DW; Haydar TF
    J Neurosci; 2016 Mar; 36(10):2926-44. PubMed ID: 26961948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.